Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
First-in-human trial naar oraal vectorvaccin tegen hiv-1
dec 2018 | HIV, Vaccinatie, Virale infecties